Parsons, Mark W., Christensen, Soren, Davis, Stephen M., McElduff, Patrick, Levi, Christopher R., Butcher, Ken S., De Silva, Deidre A., Ebinger, Martin, Barber, P. Alan, Bladin, Christopher, Donnan, Geoffrey A.. Nature Publishing Group; 2010. Pretreatment diffusion - and perfusion - MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis.

Nagakane, Yoshinari, Christensen, Soren, Bladin, Christopher F., De Silva, Deidre A., Fink, John, Kimber, Thomas E., Schultz, David W., Muir, Keith W., Tress, Brian M., Desmond, Patricia M., Davis, Stephen M., Donnan, Geoffrey A., Brekenfeld, Caspar, EPITHET Investigators,, Ma, Henry, Churilov, Leonid, Parsons, Mark W., Levi, Christopher R., Butcher, Kenneth S., Peeters, Andre, Barber, Alan. Lippincott Williams & Wilkins; 2011. EPITHET: positive result after reanalysis using baseline diffusion-weighted imaging/perfusion-weighted imaging co-registration.

Churilov, Leonid, Liu, Daniel, Ma, Henry, Christensen, Soren, Nagakane, Yoshinari, Campbell, Bruce, Parsons, Mark W., Levi, Christopher R., Davis, Stephen M., Donnan, Geoffrey A.. Wiley-Blackwell Publishing; 2013. Multiattribute selection of acute stroke imaging software platform for Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND) clinical trial.

Ma, Henry, Parsons, Mark W., Read, Stephen, Hankey, Graeme J., Markus, Romesh, Wijeratne, Tissa, Grimley, R., Mahant, N., Kleinig, Tim, Sturm, John, Lee, A., Blacker, D., Christensen, Soren, Gerraty, Richard, Krause, M., Desmond, P. M., McBride, S. J., Carey, Leanne, Howells, David W., Hsu, C. Y., Davis, Stephen M., Donnan, Geoffrey A., Campbell, Bruce C. V., Churilov, Leonid, Connelly, Alan, Yan, Bernard, Bladin, Chris, Than, Phan, Barber, Alan P.. Wiley-Blackwell; 2012. A multicentre, randomized, double-blinded, placebo-controlled phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).

Davis, Stephen, Campbell, Bruce, Christensen, Soren, Ma, Henry, Desmond, Patricia, Parsons, Mark, Levi, Christopher, Bladin, Christopher, Barber, P. Alan, Donnan, Geoffrey. Springer; 2012. Perfusion/diffusion mismatch is valid and should be used for selecting delayed interventions.

Tipirneni-Sajja, Aaryani, Christensen, Soren, Albers, Gregory W., Straka, Matus, Inoue, Manabu, Lansberg, Maarten G., Mlynash, Michael, Bammer, Roland, Parsons, Mark W., Donnan, Geoffrey A., Davis, Stephen M.. Sage Publications; 2017. Prediction of final infarct volume on subacute MRI by quantifying cerebral edema in ischemic stroke.

Ebinger, Martin, Christensen, Soren, De Silva, Deidre A., Parsons, Mark W., Levi, Christopher R., Butcher, Kenneth S., Bladin, Christopher F., Barber, Alan, Donnan, Geoffrey A., Davis, Stephen M.. American Heart Association; 2009. Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point.

Carey, Leeanne M., Crewther, Sheila, Rose, Stephen, Palmer, Susan, Bougeat, Pierrick, Campbell, Bruce C. V., Christensen, Soren, Macaulay, S. Lance, Favaloro, Jenny, O' Collins, Victoria, Mcbride, Simon, Bates, Susan, Salvado, Olivier, Cowley, Elise, Dewey, Helen, Wijeratne, Tissa, Gerraty, Richard, Phan, Thanh G., Yan, Bernard, Parsons, Mark W., Bladin, Chris, Barber, P. Alan, Read, Stephen, Lindén, Thomas, Wong, Andrew, Lee, Andrew, Kleinig, Tim, Hankey, Graeme J., Blacker, David, Markus, Romesh, Leyden, James, Krause, Martin, Grimley, Rohan, Mahant, Neil, Connelly, Alan, Jannes, Jim, Sturm, Jonathan, Davis, Stephen M., Donnan, Geoffrey A., START Research Team,, Wilson, William, Howells, David W., Churilov, Leonid, Ma, Henry, Tse, Tamara. Sage; 2015. STroke imAging pRevention and treatment (START): a longitudinal stroke cohort study: clinical trials protocol.

Campbell, Bruce C. V., Costello, Craig, Lansberg, Maarten G., Mlynash, Michael, Olivot, Jean-Marc, Straka, Matus, Bammer, Roland, Albers, Gregory W., Donnan, Geoffrey A., Davis, Stephen M., Christensen, Soren, Ebinger, Martin, Parsons, Mark W., Desmond, Patricia M., Barber, P. Alan, Butcher, Kenneth S., Levi, Christopher R., De Silva, Deidre A.. S. Karger AG; 2011. Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation.

De Silva, Deidre A., Fink, John N., Davis, Stephen M., Christensen, Soren, Ebinger, Martin, Bladin, Christopher, Levi, Christopher R., Parsons, Mark, Butcher, Ken, Barber, P. Alan, Donnan, Geoffrey A.. Lippincott Williams & Wilkins; 2009. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET).

Tu, Hans T. H., Campbell, Bruce C. V., Bladin, Christopher F., Donnan, Geoffrey A., Davis, Stephen M., Christensen, Soren, Collins, Marnie, De Silva, Deidre A., Butcher, Kenneth S., Parsons, Mark W., Desmond, Patricia M., Barber, P. Alan, Levi, Christopher R.. Karger; 2010. Pathophysiological determinants of worse stroke outcome in atrial fibrillation.

Campbell, Bruce C. V., Purushotham, Archana, Olivot, Jean-Marc, Bammer, Roland, Albers, Gregory W., Donnan, Geoffrey A., Davis, Stephen M., Christensen, Soren, Desmond, Patricia M., Nagakane, Yoshinari, Parsons, Mark W., Lansberg, Maarten G., Mlynash, Michael, Straka, Matus, De Silva, Deirdre A.. Nature Publishing Group; 2012. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent.

Ebinger, Martin, Iwanaga, Takeshi, Donnan, Geoffrey A., Davis, Stephen M., Prosser, Jane F., De Silva, Deidre A., Christensen, Soren, Collins, Marnie, Parsons, Mark W., Levi, Christopher R., Bladin, Christopher F., Barber, P. Alan. American Heart Association; 2009. Clinical-diffusion mismatch and benefit from thrombolysis 3 to 6 hours after acute stroke.

Tu, Hans T. H., Campbell, Bruce C. V., Straka, Matus, Bammer, Roland, Albers, Gregory W., Donnan, Geoffrey A., Davis, Stephen M., EPITHET-DEFUSE Investigators,, Christensen, Soren, Desmond, Patricia M., De Silva, Deidre A., Parsons, Mark W., Churilov, Leonid, Lansberg, Maarten G., Mlynash, Michael, Olivot, Jean-Marc. Sage; 2015. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.